Literature DB >> 25425133

Determining the cost of obesity and its common comorbidities from a commercial claims database.

W V Padula1, R R Allen, K V Nair.   

Abstract

What is already known about this subject Obesity is highly prevalent and costly in the US. Obesity often leads to other comorbid conditions, including diabetes and hypertension. Obesity prevention efforts can reduce healthcare costs. What this study adds Obesity combined with other comorbidities significantly increases healthcare costs per patient visit. The combination of obesity and depression exacerbates costs. The most expensive series of chronic conditions in this study included obesity, diabetes, hypertension and depression. Our objectives were to determine payments made by commercial healthcare providers in the US for adults diagnosed with obesity, and those comorbid with any combination of selected chronic conditions. Using a commercial claims and encounters database (n = 3,562,717), we evaluated an adult study population that had at least one in-patient visit, outpatient visit or emergency department visit, and received a primary or secondary diagnosis of obesity. Persons were categorized by one or more comorbid diagnoses for diabetes mellitus, hypertension, depression or congestive heart failure. We adjusted for age and gender, and calculated the mean total net expenditures (in 2012, $US) for each combination of comorbid conditions based on individual visits to an in-patient, outpatient or emergency department setting. Among 50,717 claims with diagnosis of obesity, the mean net expenditure for in-patient and outpatient services was $ 1907 per patient per visit. Persons diagnosed with obesity and other comorbidities observed an increase in total net expenditures. Obesity and congestive heart failure observed the highest increase among single comorbidities at $ 5275. For persons with obesity and two other comorbidities, diabetes mellitus and depression was the highest at $ 15,226. The most expensive condition was obesity, diabetes mellitus, hypertension and depression at $ 15,733. Compared with average medical claims, persons diagnosed with obesity and other common chronic conditions experience significant increases in medical costs. These costs are often driven higher by time spent as in-patients. By controlling and reducing the prevalence of obesity, we may see significant decreases in medical expenditures.
© 2013 The Authors. Clinical Obesity © 2013 International Association for the Study of Obesity.

Entities:  

Keywords:  Comorbidity; commercial claims; cost; obesity

Mesh:

Year:  2013        PMID: 25425133     DOI: 10.1111/cob.12041

Source DB:  PubMed          Journal:  Clin Obes        ISSN: 1758-8103


  10 in total

1.  Societal Implications of Health Insurance Coverage for Medically Necessary Services in the U.S. Transgender Population: A Cost-Effectiveness Analysis.

Authors:  William V Padula; Shiona Heru; Jonathan D Campbell
Journal:  J Gen Intern Med       Date:  2015-10-19       Impact factor: 5.128

2.  Economic impacts of overweight and obesity: current and future estimates for eight countries.

Authors:  Adeyemi Okunogbe; Rachel Nugent; Garrison Spencer; Johanna Ralston; John Wilding
Journal:  BMJ Glob Health       Date:  2021-10

3.  Trends in Obesity and Medical Expenditure among Women with Diabetes, 2008-2016: Differences by Race/Ethnicity.

Authors:  Joni S Williams; Kaiwei Lu; Olaitan Akinboboye; Oluwatoyin Olukotun; Zhipeng Zhou; Sneha Nagavally; Leonard E Egede
Journal:  Ethn Dis       Date:  2020-09-24       Impact factor: 1.847

4.  Exercise increases attentional bias towards food cues in individuals classified as overweight to obese.

Authors:  Kyle D Flack; Robert E Anderson; Kylie F McFee; Richard Kryscio; Craig R Rush
Journal:  Physiol Behav       Date:  2022-01-20

5.  4-Year Cost Trajectories in Real-World Patients Matched to the Metabolic Profiles of Trial Subjects Before/After Treatment with Phentermine-Topiramate.

Authors:  James Li; Nancy L Reaven; Susan E Funk; Karen McGaughey; Martin Neovius
Journal:  Drugs Real World Outcomes       Date:  2015-06

6.  Physical Activity and Insulin Resistance in 6,500 NHANES Adults: The Role of Abdominal Obesity.

Authors:  James R Fowler; Larry A Tucker; Bruce W Bailey; James D LeCheminant
Journal:  J Obes       Date:  2020-03-26

7.  Health care costs and lost productivity costs related to excess weight in Belgium.

Authors:  Vanessa Gorasso; Isabelle Moyersoen; Johan Van der Heyden; Karin De Ridder; Stefanie Vandevijvere; Stijn Vansteelandt; Delphine De Smedt; Brecht Devleesschauwer
Journal:  BMC Public Health       Date:  2022-09-06       Impact factor: 4.135

8.  An internet-based self-administered intervention for promoting healthy habits and weight loss in hypertensive people who are overweight or obese: a randomized controlled trial.

Authors:  Rosa M Banos; Marinna S Mensorio; Ausias Cebolla; Enrique Rodilla; Gonzalo Palomar; JuanFrancisco Lisón; Cristina Botella
Journal:  BMC Cardiovasc Disord       Date:  2015-08-04       Impact factor: 2.298

9.  Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.

Authors:  William V Padula; Richard A Larson; Stacie B Dusetzina; Jane F Apperley; Rudiger Hehlmann; Michele Baccarani; Ekkehard Eigendorff; Joelle Guilhot; Francois Guilhot; Rudiger Hehlmann; Francois-Xavier Mahon; Giovanni Martinelli; Jiri Mayer; Martin C Müller; Dietger Niederwieser; Susanne Saussele; Charles A Schiffer; Richard T Silver; Bengt Simonsson; Rena M Conti
Journal:  J Natl Cancer Inst       Date:  2016-03-04       Impact factor: 13.506

10.  Are healthcare costs from obesity associated with body mass index, comorbidity or depression? Cohort study using electronic health records.

Authors:  C Rudisill; J Charlton; H P Booth; M C Gulliford
Journal:  Clin Obes       Date:  2016-04-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.